Acute effects of sarpogrelate, a 5-HT2A receptor antagonist on cytokine production in endotoxin shock model of rats

被引:16
|
作者
Nishiyama, Tomoki [1 ]
机构
[1] Kamagaya Gen Hosp, Dept Anesthesiol & Crit Care, Chiba 2730121, Japan
关键词
Serotonin (5-HT)(2A) receptor; Endotoxin shock; Cytokine; Lung injury; TUMOR-NECROSIS-FACTOR; SEPTIC SHOCK; SEROTONIN; INTERLEUKIN-6; BINDING; SEPSIS; IDENTIFICATION; INVOLVEMENT; SUBTYPES; CELLS;
D O I
10.1016/j.ejphar.2009.03.041
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Serotonin (5-HT)(2A) receptors are involved in cytokine production in infection or sepsis. Therefore, 5-HT2A receptor antagonist might be useful to treat sepsis. The present study investigates the effects of a 5-HT2A receptor antagonist, sarpogrelate on endotoxin shock. Catheters were inserted into the femoral artery and vein of Sprague-Dawley rats. First, sarpogrelate 0 (control), 3, or 10 mg/kg dissolved in 0.5 ml of distilled water has been given, followed by endotoxin 10 mg/kg in saline 0.5 ml 5 min later. Blood pressure, pulse rate and survival rate were monitored in 20 rats per dose. Blood gas and plasma cytokine concentrations were measured in 8 rats per dose. In four rats each of sarpogrelate 0, 3, or 10 mg/kg, and sham operation, the lung histology was examined. Zero, 15, and 12 rats survived for 8 h in the control. 3 mg/kg, and 10 mg/kg groups, respectively. The control group had the lowest blood pressure, pulse rate, pH and arterial oxygen tension, and the highest arterial carbon dioxide tension and plasma IL-1 beta concentration. The increase of TNF-alpha was significantly lower in 3 mg/kg group than in the control group. Pathological changes of the lung were inhibited in 3 and 10 mg/kg groups. In conclusion, sarpogrelate might be effective to decrease production of pro-inflammatory cytokines, to keep hemodynamics, to inhibit lung damage, and to decrease mortality in endotoxin shock. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:122 / 127
页数:6
相关论文
共 50 条
  • [21] Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT2A receptor (5-HT2AR) antagonist M100907
    Gilbertson, Scott R.
    Chen, Ying-Chu
    Soto, Claudia A.
    Yang, Yaxing
    Rice, Kenner C.
    Cunningham, Kathryn A.
    Anastasio, Noelle C.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (08) : 1381 - 1385
  • [22] Effect of sarpogrelate, a 5-HT2A antagonist, on platelet aggregation in patients with ischemic stroke:: Clinical-pharmacological dose-response study
    Uchiyama, Shinichiro
    Ozaki, Yukio
    Satoh, Kaneo
    Kondo, Kazuoki
    Nishimaru, Katsuya
    CEREBROVASCULAR DISEASES, 2007, 24 (2-3) : 264 - 270
  • [23] Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of Sarpogrelate
    Aly, Saida Abdel Regal
    Hossain, Murad
    Bhuiyan, Mohiuddin Ahmed
    Nakamura, Takashi
    Nagatomo, Takafumi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 110 (04) : 445 - 450
  • [24] Behavioral effects of dipropyltryptamine in rats:: evidence for 5-HT1A and 5-HT2A agonist activity
    Li, Jun-Xu
    Rice, Kenner C.
    France, Charles P.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 (04): : 283 - 288
  • [25] Differential effects of 5-HT2A and 5-HT2C receptor blockade on strategy-switching
    Baker, Phillip M.
    Thompson, Jennifer L.
    Sweeney, John A.
    Ragozzino, Michael E.
    BEHAVIOURAL BRAIN RESEARCH, 2011, 219 (01) : 123 - 131
  • [26] Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT2C receptor agonist but not by a 5-HT2A receptor antagonist
    Guy, Elizabeth Glenn
    Fletcher, Paul J.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2014, 125 : 40 - 47
  • [27] LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor
    Halberstadt, Adam L.
    Geyer, Mark A.
    PSYCHOPHARMACOLOGY, 2010, 208 (02) : 179 - 189
  • [28] Functional characteristics of serotonin 5-HT2A and 5-HT 2C receptors in the brain and the expression of the 5-HT2A and 5-HT2C receptor genes in aggressive and non-aggressive rats
    Popova N.K.
    Naumenko V.S.
    Kozhemyakina R.V.
    Plyusnina I.Z.
    Neuroscience and Behavioral Physiology, 2010, 40 (4) : 357 - 361
  • [29] Effects of R-102444, an orally active 5-HT2A receptor antagonist, in rat models of peripheral vascular disease
    Ogawa, T
    Sugidachi, A
    Tanaka, N
    Fujimoto, K
    Asai, F
    VASCULAR PHARMACOLOGY, 2004, 41 (01) : 7 - 13
  • [30] Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement
    Fletcher, Paul J.
    Rizos, Zoe
    Noble, Kevin
    Soko, Ashlie D.
    Silenieks, Leo B.
    Le, Anh Dzung
    Higgins, Guy A.
    NEUROPHARMACOLOGY, 2012, 62 (07) : 2288 - 2298